CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.
A bipartisan group of over 30 senators recently wrote a letter to CMS to ask the agency to reevaluate the fiscal year (FY) 2024 Inpatient Prospective Payment System (IPPS) proposed rule.
Although commercial payers typically pay more per claim, it is significantly easier for providers to get reimbursed by Medicare, according to a May 2023 Crowe Revenue Cycle Analytics report.
NAHRI is hosting the sixth annual Revenue Integrity Week June 5–9. Join us in celebrating the hard work of revenue integrity professionals with team building activities, recognition programs, games, and prizes.
The Office of Inspector General (OIG) recently released an audit report on prior authorization and payment denials by Medicare Advantage Organizations (MAO). The result raised OIG concerns about certain MAO denial practices impacting beneficiary access to medically necessary care.
The COVID-19 PHE is expected to conclude at the end of the day on May 11. To assist providers during this transition, CMS released an FAQ to clarify the expiration timelines for various Medicare waivers and flexibilities.
NAHRI members learned about the latest association news, tips for managing the unwinding of COVID-19 public health emergency (PHE) waivers, and more on the April 25 NAHRI Quarterly Call.
